Filipe Pereira, co-founder of Asgard Therapeutics, awarded with a BII PreSeed grant

Posted on April 1, 2020

The BioInnovation Institute (BII) awarded Filipe Pereira, co-founder of Asgard Therapeutics, with DKK 3.5M to advance pre-clinical development of dendritic cell reprogramming and define its regulatory roadmap towards the clinic.

Swedish project funded with DKK 3.5M in PreSeed program

Filipe Pereira, co-founder of Asgard Therapeutics, awarded with a BII PreSeed grant

Asgard Therapeutics awarded Vinnova's Innovative Startup Step 2

Filipe Pereira, Cristiana Pires and Fábio Rosa, co-founders of Asgard Therapeutics, awarded with the Lund University and Sparbanken Skåne's prize for future innovations